Manufacturer record
Bio Tech Formulation: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Bio Tech Formulation (Andhra Pradesh) was declared Not of Standard Quality in January 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: BT229, Non-Sterile Not for Intravenous Administration Concentrated Acidic Solution (exp Jun 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: Appearance of solution, assay of sodium, potassium, calcium, magnesium and total chloride. Particulate contamination and description. Listed in the January 2025 alert.
Records by type
1 record linked to Bio Tech Formulation in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Non-Sterile Not for Intravenous Administration Concentrated Acidic Solution | Batch BT229Mfg Jul 2024 · Exp Jun 2025 | Appearance of solution, assay of sodium, potassium, calcium, magnesium and total chloride. Particulate contamination and descriptionAssay | CDL KolkataCDSCO lab | Jan 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.